Aytu BioPharma Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Aytu BioPharma.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Aytu BioPharma.

Recommendation Trends

Rating	Mar '23	Apr '23	May '23	Jun '23	Jul '23
Strong Buy	1	1	1	1	1
Buy	1	1	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Naz Rahman Maxim Group	Maxim Group	Strong Buy Initiates $5	Strong Buy	Initiates	$5	+190.70%	Aug 9, 2023
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+1,062.79%	May 31, 2023
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $220 → $120	Strong Buy	Maintains	$220 → $120	+6,876.74%	Jul 21, 2022
Jennifer Kim Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $220 → $100	Buy	Maintains	$220 → $100	+5,713.95%	May 17, 2022
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $480 → $220	Strong Buy	Maintains	$480 → $220	+12,690.70%	Apr 28, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

71.75M

from 81.00M

-11.42%

from 81.00M

Revenue Next Year

71.00M

from 71.75M

-1.05%

from 71.75M

EPS This Year

0.61

from -2.86

EPS Next Year

0.56

from 0.61

-8.33%

from 0.61

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2020	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	27.63M	65.63M	96.67M	107.40M	81.00M	71.75M	71.00M	70.72M
Revenue Growth	277.47%	137.52%	47.29%	11.10%	-24.58%	-11.42%	-1.05%	-0.40%
EPS	-60.28	-69.61	-74.01	-5.11	-2.86	0.61	0.56	1.49
EPS Growth	-	-	-	-	-	-	-8.33%	165.45%
Forward PE	-	-	-	-	-	2.81	3.07	1.15
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	73.9M	73.1M	72.8M
Avg	71.8M	71.0M	70.7M
Low	68.9M	68.2M	67.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-8.8%	1.9%	2.5%
Avg	-11.4%	-1.1%	-0.4%
Low	-14.9%	-4.9%	-4.3%

EPS Forecast

EPS	2025	2026	2027
High	0.63	0.58	1.53
Avg	0.61	0.56	1.49
Low	0.59	0.54	1.43

EPS Growth

EPS Growth	2025	2026	2027
High	-	-5.6%	173.3%
Avg	-	-8.3%	165.5%
Low	-	-11.9%	155.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.